Beijing Wandong Medical Technology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000PZ1
CNY
16.16
-2.07 (-11.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,509.51
1,224.81
1,106.18
1,141.22
1,114.73
968.56
941.42
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,509.51
1,224.81
1,106.18
1,141.22
1,114.73
968.56
941.42
Raw Material Cost
987.21
730.28
643.67
643.67
584.84
549.80
565.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.21
1.70
1.83
1.96
3.33
1.15
1.79
Selling and Distribution Expenses
302.05
307.50
244.35
246.11
212.95
241.16
237.97
Other Expenses
14.77
14.18
12.55
9.68
6.59
4.64
3.74
Total Expenditure (Excl Depreciation)
1,439.15
1,181.28
1,015.35
988.54
867.05
838.55
842.35
Operating Profit (PBDIT) excl Other Income
70.4
43.5
90.8
152.7
247.7
130
99.1
Other Income
110.43
140.58
126.25
87.69
78.85
78.05
41.13
Operating Profit (PBDIT)
219.31
222.37
253.65
273.76
354.85
245.36
215.05
Interest
2.21
1.70
1.83
1.96
3.33
1.15
1.79
Exceptional Items
-7.30
35.07
-20.22
-24.73
-47.18
-12.45
-1.16
Gross Profit (PBDT)
522.30
494.53
462.51
497.55
529.88
418.76
376.18
Depreciation
42.56
40.36
38.96
40.25
40.85
40.85
39.08
Profit Before Tax
167.25
215.38
192.63
206.83
263.49
190.91
173.02
Tax
8.22
22.52
20.40
26.96
45.49
26.13
23.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
157.35
188.54
175.37
183.19
220.67
168.88
153.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
157.35
188.54
175.37
183.19
220.67
168.88
153.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.29
2.27
-3.33
-2.93
-2.39
-3.86
-4.12
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
158.64
190.81
172.04
180.26
218.27
165.02
149.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,767.55
4,711.47
4,605.40
2,396.01
2,282.03
2,089.00
1,964.52
Earnings per share (EPS)
0.22
0.27
0.27
0.34
0.41
0.32
0.28
Diluted Earnings per share
0.22
0.27
0.27
0.34
0.41
0.32
0.28
Operating Profit Margin (Excl OI)
4.39%
3.38%
7.99%
12.78%
21.09%
13.06%
14.32%
Gross Profit Margin
13.9%
20.88%
20.94%
21.65%
27.3%
23.93%
22.53%
PAT Margin
10.42%
15.39%
15.85%
16.05%
19.8%
17.44%
16.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 23.24% vs 10.72% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -16.88% vs 10.93% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 33.13% vs -35.79% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 29.41% vs -5.56% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Beijing Wandong Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,509.51
0
1,509.51
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,509.51
0
1,509.51
Raw Material Cost
987.21
0
987.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.21
0
2.21
Selling and Distribution Expenses
302.05
0
302.05
Other Expenses
14.77
0.00
14.77
Total Expenditure (Excl Depreciation)
1,439.15
0
1,439.15
Operating Profit (PBDIT) excl Other Income
70.35
0.00
70.35
Other Income
110.43
0
110.43
Operating Profit (PBDIT)
219.31
0
219.31
Interest
2.21
0
2.21
Exceptional Items
-7.30
0
-7.30
Gross Profit (PBDT)
522.30
0
522.30
Depreciation
42.56
0
42.56
Profit Before Tax
167.25
0
167.25
Tax
8.22
0
8.22
Provisions and contingencies
0
0
0.00
Profit After Tax
157.35
0
157.35
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
157.35
0
157.35
Share in Profit of Associates
0
0
0.00
Minority Interest
1.29
0
1.29
Other related items
0.00
0.00
0.00
Consolidated Net Profit
158.64
0
158.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,767.55
0
4,767.55
Earnings per share (EPS)
0.22
0
0.22
Diluted Earnings per share
0.22
0
0.22
Operating Profit Margin (Excl OI)
4.39%
0%
0.00
4.39%
Gross Profit Margin
13.90%
0%
0.00
13.90%
PAT Margin
10.42%
0%
0.00
10.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 150.95 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 23.24% vs 10.72% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 15.86 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.88% vs 10.93% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.89 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 33.13% vs -35.79% in Dec 2023

Annual - Interest
Interest 0.22 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 29.41% vs -5.56% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.39%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023